Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Shares Outstanding (2018 - 2025)

Historic Shares Outstanding for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to $189.7 million.

  • Revolution Medicines' Shares Outstanding rose 1309.26% to $189.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.7 million, marking a year-over-year increase of 1309.26%. This contributed to the annual value of $185.9 million for FY2024, which is 1288.73% up from last year.
  • As of Q3 2025, Revolution Medicines' Shares Outstanding stood at $189.7 million, which was up 1309.26% from $186.9 million recorded in Q2 2025.
  • Revolution Medicines' 5-year Shares Outstanding high stood at $189.7 million for Q3 2025, and its period low was $73.4 million during Q1 2021.
  • Over the past 5 years, Revolution Medicines' median Shares Outstanding value was $109.1 million (recorded in 2023), while the average stood at $124.1 million.
  • In the last 5 years, Revolution Medicines' Shares Outstanding soared by 107.93% in 2022 and then soared by 8213.82% in 2023.
  • Quarter analysis of 5 years shows Revolution Medicines' Shares Outstanding stood at $74.1 million in 2021, then grew by 21.94% to $90.4 million in 2022, then surged by 82.14% to $164.7 million in 2023, then increased by 12.89% to $185.9 million in 2024, then increased by 2.05% to $189.7 million in 2025.
  • Its Shares Outstanding stands at $189.7 million for Q3 2025, versus $186.9 million for Q2 2025 and $186.3 million for Q1 2025.